feed,title,long_url,short_url
Benzinga,Kiadis announces new data demonstrating FC21-NK cells were well tolerated and showed encouraging signs of antitumor and suspected antimicrobial activity in 13 patients with relapsed/refractory acute myeloid leukemia (R/R AML),https://www.benzinga.com/pressreleases/20/08/g17297308/kiadis-announces-new-data-demonstrating-fc21-nk-cells-were-well-tolerated-and-showed-encouraging-s,https://j.mp/31FMGYJ
